robert kennedy glp 1 The MAHA agenda won't include expanding GLP-1 coverage — for now RFK Jr. on coverage for

Explore the latest insights on access, mental health, and off-label use in T1D.

Adults with type 2 diabetes assigned an SGLT2 inhibitor or a GLP-1 receptor agonist during cardiovascular outcomes trials derived benefit from the therapies regardless of whether they were prescribed insulin, according to a meta-analysis.In an analysis of data across eight large, multiyear CV outcomes trials for three classes of diabetes agents, researchers also found that participants using

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

The prescription medication Ozempic is used to treat Type 2 diabetes